Keywords: india, ranbaxy, sees, q1, profits, soar, indian
India's Ranbaxy sees Q1 profits soar 78%
Article | 12 May 2003
Indian drugmaker Ranbaxy Laboratories says that group net profit leapt77.8% to 1.73 billion rupees ($36.5 million) in the first quarter of 2003, with ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
